论文部分内容阅读
贫血是癌症患者常见的并发症,约50%的癌症患者在其病程中将会出现贫血[1];而放、化疗可使癌症患者的贫血进一步加重。因此,有效纠正癌性贫血具有临床实际意义。我院应用促红细胞生成素(EPO)治疗癌性贫血患者20例,取得较好效果,现报告如下。1资料与方法1.1病例选择我科收治癌症
Anemia is a common complication in cancer patients, and about 50% of cancer patients will develop anemia during their course of disease [1]. However, radiotherapy and chemotherapy may further aggravate anemia in cancer patients. Therefore, the effective correction of cancer anemia has clinical significance. 20 cases of cancer anemia patients treated with erythropoietin (EPO) in our hospital, and achieved good results, are as follows. 1 Materials and Methods 1.1 Case Selection I received cancer treatment